MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/14796694.2025.2609972

Медицинская библиотека · Future oncology (London, England) · 2025

Impact of radiation dose to immune cells on survival in patients with extensive-stage small cell lung cancer receiving consolidative thoracic radiotherapy after chemoimmunotherapy.

Feng Changxing, Wang Kang, Xu Fuhao, Li Li, Yuan Shuanghu

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Consolidative thoracic radiotherapy (RT) following chemo-immunotherapy is increasingly used in extensive-stage small cell lung cancer (ES-SCLC). This study investigates the prognostic value of the estimated radiation dose to immune cells (EDRIC) and its determinants in these patients.

METHODS

This retrospective study included 173 ES-SCLC patients between 2020 and 2023. EDRIC was calculated as a function of the number of fractions and the average doses to the lungs, heart, and remaining body. Kaplan-Meier and Cox regression analyses were performed to evaluate overall survival (OS) and progression-free survival (PFS).

RESULTS

GTV, PTV, and N stage were positively correlated with EDRIC (r = 0.2577, p = 0.0006; r = 0.3541, p < 0.01; r = 0.2259, p = 0.0028), while lymphocyte nadir was negatively correlated (r = -0.2190, p = 0.0038). Median OS and PFS were longer in the EDRIC ≤4.68 Gy group (OS: 24.9 vs. 17.4 months, p = 0.003; PFS: 12.4 vs. 10.1 months, p = 0.038). Patients in the EDRIC ≤4.68 Gy group had significantly better OS (HR = 0.56, p = 0.003) and PFS (HR = 0.68, p = 0.039). Bone metastasis was associated with worse OS (HR = 1.88, p = 0.002), and liver metastasis with shorter PFS (HR = 2.05, p = 0.001).

CONCLUSIONS

EDRIC is an independent predictor of OS and PFS in ES-SCLC. These findings highlight the need to optimize radiation exposure to the immune system in cancer treatment.

Для цитирования: Feng Changxing, Wang Kang, Xu Fuhao, Li Li, Yuan Shuanghu. Impact of radiation dose to immune cells on survival in patients with extensive-stage small cell lung cancer receiving consolidative thoracic radiotherapy after chemoimmunotherapy.. Future oncology (London, England). 2025. DOI: 10.1080/14796694.2025.2609972.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.